EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

A Multifunctional MIL-101-NH2(Fe) Nanoplatform for Synergistic Melanoma Therapy

Jinlu Shang iD, Yongjun Chen, Fangliang Wang, Jing Yang, Yi Li, Liuxuan Yang iD, Xiuqiong Liu, Zhirong Zhong iD, Chaochi Yue, Meiling Zhou iD

International Journal of Nanomedicine · 2025

DOI: 10.2147/ijn.s502089 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2025. Verfasst von Jinlu Shang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, West China Hospital Sichuan University Jintang Hospital, Chengdu, Sichuan, 610400, People's Republic of China. Hauptthemen laut MEDLINE: Doxorubicin, Melanoma, Experimental, Nanoparticles, Melanoma. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinMelanoma, ExperimentalNanoparticlesMelanomaAnimalsMiceIndocyanine GreenCell Line, TumorDrug LiberationPhotosensitizing AgentsReactive Oxygen SpeciesDrug CarriersMice, Inbred C57BLAntineoplastic AgentsSkin NeoplasmsPhotochemotherapy

Stichwörter der Autor:innen

MIL-101-NH2(Fe)chemodynamic therapychemotherapymelanomaphotodynamic therapyphotothermal therapy

Substanzen

DoxorubicinIndocyanine GreenPhotosensitizing AgentsReactive Oxygen SpeciesDrug CarriersAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Pharmacy, West China Hospital Sichuan University Jintang Hospital, Chengdu, Sichuan, 610400, People's Republic of China.
  • Department of Pharmacy, The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan, 646000, People's Republic of China.
  • Chongqing Key Laboratory for Pharmaceutical Metabolism Research, Chongqing Pharmacodynamic Evaluation Engineering Technology Research Center, College of Pharmacy Chongqing Medical University, Chongqing, 400016, People's…
  • Department of Nuclear Medicine, The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan, 646000, People's Republic of China.
  • Department of Pharmaceutical Sciences, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, 646000, People's Republic of China.
  • Department of Traditional Chinese Medicine, The Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan, 646000, People's Republic of China.

ORCID-Profile: Jinlu Shang, Liuxuan Yang, Zhirong Zhong, Meiling Zhou

Zitieren

APA

Shang, J., Chen, Y., Wang, F., Yang, J., Li, Y., Yang, L., Liu, X., Zhong, Z., Yue, C., & Zhou, M. (2025). A Multifunctional MIL-101-NH2(Fe) Nanoplatform for Synergistic Melanoma Therapy. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s502089

Vancouver

Shang J, Chen Y, Wang F, Yang J, Li Y, Yang L, et al. A Multifunctional MIL-101-NH2(Fe) Nanoplatform for Synergistic Melanoma Therapy. International Journal of Nanomedicine. 2025. doi:10.2147/ijn.s502089

BibTeX
@article{Shang2025,
  author = {Shang, Jinlu and Chen, Yongjun and Wang, Fangliang and Yang, Jing and Li, Yi and Yang, Liuxuan and Liu, Xiuqiong and Zhong, Zhirong and Yue, Chaochi and Zhou, Meiling},
  title = {A Multifunctional MIL-101-NH2(Fe) Nanoplatform for Synergistic Melanoma Therapy},
  journal = {International Journal of Nanomedicine},
  year = {2025},
  doi = {10.2147/ijn.s502089}
}
Kostenlos starten →